We have previously demonstrated that a slight increase in intracellular superoxide (O 2 KÀ ) anion confers resistance to death stimuli. Using pharmacological and molecular approaches to manipulate intracellular O 2 KÀ , here we report that an increase in intracellular O 2 KÀ anion induces Na þ /H þ exchanger 1 (NHE-1) gene promoter activity resulting in increased NHE-1 protein expression, which strongly correlates with the resistance of cells to death stimuli. In contrast, exposure to exogenous hydrogen peroxide suppressed NHE-1 promoter activity and gene expression, and increased cell sensitivity to death triggers. Furthermore, the increase in cell sensitivity to death upon downregulation of NHE-1 gene expression correlates with reduced capacity of cells to recover from an acid load, while survival upon overexpression of NHE-1 appears independent of its pump activity. These findings indicate that NHE-1 is a redox-regulated gene, and provide a novel intracellular target for the redox control of cell death sensitivity.
Introduction
The involvement of reactive oxygen species (ROS) in biological systems over the years has been restricted to damaging reactions; however, there is mounting evidence to the contrary implicating ROS as important signaling molecules in a variety of physiological processes. In this regard, the regulation of tumor cell sensitivity to death stimuli was shown to be a function of the balance between intracellular levels of superoxide (O 2 KÀ ) and hydrogen peroxide (H 2 O 2 ). [1] [2] [3] [4] Indeed, an increase in intracellular O 2 KÀ concentration, achieved by either its direct overproduction, 5 drug induction, 6 ,7 activation of the small GTPase Rac1 8 or as a result of an inhibition of the O 2 KÀ scavenger Cu/Zn superoxide dismutase (Cu/Zn SOD), 6 inhibits tumor cell apoptosis triggered by either the ligation of the CD95 receptor or anticancer drugs. In contrast, H 2 O 2 is a widely accepted trigger of cell death 9 and nontoxic levels of H 2 O 2 sensitize cells to death stimuli. 10 Earlier reports have highlighted the regulatory role of intracellular redox status on death signaling by demonstrating an effect on caspase family protease, the central executioners of apoptotic signals. 11, 12 However, a complete understanding of redox regulation of cell survival pathways is still lacking. Interestingly, recent data from our group suggested that redox regulation of cell survival in tumor cells could be associated with regulation of intracellular pH (pHi). 2 Regulation of pHi is accomplished via active extrusion of H þ by the Na þ /H þ exchanger (NHE), a membrane antiporter expressed in a variety of cell types. In mammalian cells, the NHE family consists of nine isoforms, Na þ /H þ exchanger 1 (NHE-1) to NHE-9. NHE-1, the first isoform cloned, is ubiquitous in its distribution, while other isoforms have more restricted or specialized functions. [13] [14] [15] 16 Interestingly, in addition to its role as a principal regulator of pHi and cell volume, NHE-1 has been implicated in cell proliferation, survival and transformation. Growth factors such as serum, epidermal growth factor (EGF) and phorbol ester myristyl acetate (PMA), have all been shown to activate NHE-1 promoter activity. 17 Not only is it intriguing that a slight pro-oxidant intracellular environment also shares the prosurvival and proliferative properties of NHE-1, but more interestingly the link between intracellular ROS and NHE-1 is further supported by the observations that the aforementioned inducers of NHE-1 gene expression have also been implicated in intracellular ROS production.
Intrigued by these findings, we set out to investigate if the prosurvival activity of O 2 KÀ and NHE-1 was a matter of serendipity, or the result of a true cause and effect relationship. Therefore, we first asked if regulation of NHE-1 gene expression affected cell sensitivity to apoptosis and whether O 2 KÀ -induced survival could be mediated trough redox regulation of NHE-1 gene expression. Here, we report that an increase in NHE-1 protein inhibited death execution, while silencing NHE-1 with specific NHE-1 siRNA increased cell sensitivity to death stimuli. Furthermore, using three different murine cell lines (L6 muscle cells, MCT renal fibroblasts and NIH3T3 fibroblasts), the human glioma cells (U87), and a human melanoma cell line (M14), we present evidence that intracellular O 2 KÀ is a signal for the activation of the NHE-1 gene promoter that leads to an increase in NHE-1 protein expression. In contrast, exogenous addition of H 2 O 2 inhibited NHE-1 promoter activity, decreased NHE-1 protein level, and sensitized cells to death triggers.
Results

Regulation of NHE-1 gene expression affects cells sensitivity to death triggers
Recent evidence suggests that in addition to regulating pHi, NHE-1 could be a critical regulator of cell sensitivity to death stimuli. 18 In agreement with this recent finding, transfection of NIH3T3 cells with increasing concentrations of the pECE-NHE-1 vector resulted in a dose-dependent increase in NHE-1 protein expression that correlated with inhibition of staurosporine-induced cell death (Figure 1a and b) . Interestingly, increase in NHE-1 expression and survival did not correlate with a significant increase in pHi and acid-loading recovery capacity of the cells (Figure 1c and d) . To the contrary, silencing of NHE-1 expression with a specific NHE-1 siRNA led to a significant sensitization of NIH3T3 cells to the same trigger (Figure 2a and b) . Moreover, silencing of NHE-1 led to a maximum of 0.16 U decrease in pHi in cells transfected with 100 nM NHE-1 siRNA (Figure 2c ) and a concentration-dependent decreased acid-loading recovery capacity compared to control-transfected cells (Figure 2d) . Similar results were obtained with etoposide-induced death (data not shown). It should be noted that in both experiments, cell death was assessed by the bgalactosidase protein (bgal) assay as described in Materials and Methods and reported previously. 8 We used this method because it allows for the measurement of cell death in transfected cells only. This approach is particularly important when overexpressing NHE-1 keeping in view the transfection efficiency of B30% usually obtained in these experiments. Hence, measurement of cell death in bgal-transfected cells is a better index of the effect of Figure 2 Silencing of NHE-1 increases cells sensitivity to staurosporine-induced cell death and inhibits cells' capacity to recover from an acid load. (a) NHE-1 protein expression was silenced using increasing concentrations of a specific NHE-1 siRNA (NHE-1siRNA) or a control siRNA (CosiRNA) as described in Materials and Methods. Gel represents one transfection out of three. (b) At 48 h postsilencing, cell death was triggered for 18 h with 0.5 mM staurosporine before being assessed using the bgal assay as described in Materials and Methods. (c) pHi and (d) acid-loading recovery capacity were measured as described in Materials and Methods. (e) At 48 h post-transfection, NIH3T3 cells mock transfected, transfected with 6 mg pECE-NHE-1 or 100 nM NHE-1siRNA, were incubated with 0.5 mM staurosporine for 12 h before caspase activity was measured as described in Materials and Methods. Figure 3a , silencing of NHE-1 gene expression (Figure 3b ) did not prevent DDC-induced increase in intracellular level of O 2 KÀ in NIH3T3 cells; however, NHE1siRNA prevented DDC-mediated inhibition of staurosporineinduced cell death (Figure 3c ). In these experiments, cell death was assessed using the crystal violet assay, as the transfection efficiency obtained with NHE-1siRNA was routinely around 90% (data not shown). As such, the difference in the assay used to assess cell death might account for variance in the actual percentage of cell death in Figure 3 
Intracellular superoxide activates NHE-1 promoter activity
A well-documented activator of NHE-1 gene expression is the presence of serum in the cell culture medium. 17 Indeed, mouse fibroblast NIH3T3 cells, stably transfected with the 1.1-kb proximal fragment of the mouse NHE1 promoter/enhancer inserted 5 0 to the luciferase gene (NIH3T31A8) 17 and grown in 10% serum, showed higher NHE-1 promoter activity compared to the same cells grown in 0.5% serum for 18 h ( Figure 4a ). Moreover, serum-dependent increase in NHE-1 promoter activity correlated with a higher level of NHE-1 protein compared to serum-starved cells (Figure 4b ). Incidentally, in addition to an increase in NHE-1 promoter activity, the presence of serum was also a stimulus for the intracellular generation of O 2 KÀ that could be partially inhibited by the widely used oxidase inhibitor diphenyleneiodonium (DPI) (Figure 4c 
Rac1-mediated survival is dependent upon NHE-1 protein expression
In nonphagocytic cells, production of O 2 KÀ has long been attributed to mitochondrial respiration. However, during the 1990s it became increasingly evident that nonphagocytic cells could also produce low levels of O 2 KÀ through mechanisms similar to those in phagocytes. In particular, Sudaresan et al. 20 showed the production of O 2 KÀ upon growth factor-mediated activation of the small GTPase Rac1 in fibroblasts that could be inhibited by the expression of RacN17, the dominantnegative allele of Rac1. Moreover, Irani et al. 21, 22 clearly demonstrated the role for Rac1-mediated O 2 KÀ production in cell cycle regulation in tumor cells. Coincidently, using Rac1 loss-of-function mutants, we previously demonstrated that resistance to staurosporine-and etoposide-induced cell death in NIH3T3 and in the human melanoma cells M14 correlated with the ability of Rac1 to produce intracellular O 2 KÀ . To support further a role for Rac1 activation in the induction of NHE-1 promoter activity, we used mouse muscle L6 cells (L6 1.1 Kb), 23 mouse renal fibroblast MCT cells (MCT 1.1 kb) and NIH3T31A8 cells stably transfected with the 1.1-kb proximal fragment of the mouse NHE1 promoter/enhancer inserted 5 0 to a luciferase gene. These cells were transiently transfected with a constitutively active form of Rac1, RacV12 or an empty pIRES vector. A significant increase in NHE-1 promoter activity was observed upon RacV12 transfection compared to the same cells transfected with the pIRES control vector in all three cell types (Figure 8a ). Similar results were obtained in NIH3T3 cells stably transfected with the 1.1-kb proximal fragment of the mouse NHE1 promoter/enhancer inserted 5 0 to a chloremphenicol acetyl transferase gene (CAT), NIH3T3CatC2 and NIH3T3CatB3 cells (Figure 8b) . Hence, data obtained with two different reporter genes in five different cell lines confirm that activation of Rac1 stimulates NHE-1 promoter activity.
In addition to triggering intracellular production of O 2 KÀ , activation of Rac1 has also been shown to regulate actin polymerization and Jun kinase (JNK) activation. 24 In order to support that Rac1-mediated induction of NHE-1 gene promoter activity was indeed a function of an increase in intracellular O 2 KÀ , NIH3T31A8 cells were transfected with partial myc-tagged loss-of-function mutants of Rac1 containing specific amino-acid substitutions in the activated RacV12 background. 8 The RacV12L37 mutant activates JNK but is defective in inducing actin polymerization, whereas the RacV12H40 mutant induces actin polymerization but is defective in JNK activation. However, both of these mutations still retain the ability to generate intracellular O 2 KÀ . 25 In contrast, the critical role of histidine 103 (H103) and lysine 166 (K166) of Rac1 protein in O 2 KÀ production has been established. 26 Note that these mutants are the same as those we used to demonstrate that O 2 KÀ production was involved in Rac1-mediated survival.
8 NIH3T31A8 cells were cotransfected with the pCMVbgal plasmid, which encodes for the bgal and either the pIRES control vector or pIRESRacV12, pIRESRacV12L37, pIRESRacV12H40, pIRESRacV12-H103A or pIRESRacV12K166E. At 48 h post-transfection, cells were serum starved (0.5% serum) for 18 h before assessing NHE-1 promoter activity. Cells were serum starved in order to prevent serum-induced activation of the promoter and background activity of the endogenous Rac. Cotransfection with the pCMVbgal plasmid was used to standardize transfection efficiency within the different constructs. It should be pointed out that the bgal activity for each transfection and the level of expression of Rac mutants 48 h post-transfection in NIH3T31A8 cells were not significantly different (data not shown). Hence, the differences in the ability of different plasmids to induce NHE-1 promoter activity could not be attributed to differences in protein expression. In addition, we confirmed that transient transfection of NIH3T3 1A8 cells with pIRESRacV12, pIRESRacV12L37and pIRESRacV12H40 induced a significant increase in intracellular O 2 KÀ compared to vector control-transfected cells, while a minimum induction was observed with pIRESRacV12H103A or pIRESRacV12K166E (Figure 9a ). Rac1-mediated production of intracellular O 2 KÀ always correlated with the ability of Rac1 to increase NHE-1 promoter activity (Figure 9b) (Figure 10a Rac-induced survival is dependent on NHE-1 expression. M14 cells constitutively expressing an active form of Rac1 (M14RacV12) and its vector -expressing counterpart (M14pIRES) were cotransfected with an NHE-1 specific siRNA (NHE-1siRNA) or a control siRNA (cosiRNA) and 0.5 mg pCMVbgal as described in Materials and Methods. At 48 h post-transfection, (a) level of NHE-1 protein, (b) cell death was induced with 40 mM etoposide for 18 h and (c) acid-loading recovery capacity was assessed. Band intensity of NHE-1/b actin from three different experiments has been averaged7S.E. Acid-loading recovery capacity was assessed as described in Materials and Methods. Cell death was determined by the bgal assay as described in Materials and Methods. Results represent an average of three experiments performed in duplicate7S.E. *Po0.002 cells to etoposide-induced death as shown by the measurement of caspase activity and NHE-1 protein expression in Figure 10e . Taken together, these data provided strong evidence to support that the expression of NHE-1 is redox regulated, with opposing effects of O 2 KÀ and H 2 O 2 on its promoter activity and protein expression. Moreover, the use of two different reporter gene systems rules out the possibility that the observed inhibitory effect on NHE-1 promoter activity could have been attributed to the inhibitory effect of H 2 O 2 on the reporter gene (luciferase or CAT) itself.
Discussion
The predominant cellular function of the ubiquitously expressed Na þ /H þ exchanger isoform 1, NHE-1, is the regulation of intracellular pH (pHi). The expression of NHE-1 is induced by a variety of external stimuli, such as serum, acidosis, PKC and cell proliferation (for review see 16 ); however, the signals involved in NHE-1 gene transcription remain largely unknown. Recent evidence strongly suggests that, in addition to regulating pHi, NHE-1 could be a critical regulator of cell sensitivity to death stimuli. 18 In agreement with these recent findings we show that level of NHE-1 gene expression regulates the sensitivity of mouse fibroblast NIH3T3 cells, the human U87 glioma cells and the human melanoma M14 cells to etoposide-or staurosporine-induced cell death. In addition, we provide evidence that NHE-1 is a redox-regulated gene with a clear divergent effect of O KÀ through activation of the nuclear protein poly (ADP)-ribose polymerase. 10 In light of that, inhibition of NHE-1 promoter activity by H 2 O 2 could be a consequence of a decrease in intracellular O2
KÀ concentration. This hypothesis is supported by data showing that DDC-induced increase in intracellular O2
KÀ can prevent H 2 O 2 -mediated inhibition of NHE-1 promoter activity (Kumar A and Clement MV, unpublished data). It should be pointed out that in a previous study using rat cardiomyocytes NHE-1 gene transcription was shown to be induced by H 2 O 2 . 30 Although, the paradoxical effect of H 2 O 2 in these two systems is not clearly understood, it is plausible that a different set of redox-regulated transcription factors are involved in myocytes compared to cells used in the present study. Notwithstanding the differences, our results provide strong evidence to implicate intracellular redox status in the regulation of NHE-1 promoter activity and gene expression.
These results could have important relevance in tumor cells. Indeed, there is evidence to suggest that transformation and proliferation are favored during intracellular redox imbalance leading to a pro-oxidant intracellular milieu. 19 To that effect, mitogenic signal triggered by the oncogene Ras in a fibroblast cell line was attributed to Rac-dependent intracellular production of O2 KÀ , thereby lending support to the hypothesis that O2
KÀ acts as an important proliferative signal during tumorigenesis. 22 Along similar lines, Reshkin et al. 31 have recently demonstrated that just as efficient Ras-mediated transformation requires activation of Rac, NHE-1 protein expression was equally implicated in malignant transformation and the development of the transformed phenotype. 32 Taken together, these findings suggest that, in addition to activation of the exchanger leading to alkaline pHi, redox regulation of NHE-1 gene expression could be critical in tumor cell formation. In particular, resistance of tumor cells to death triggers due to a slight increase in intracellular O 2 KÀ could be linked to the regulation of NHE-1 protein expression.
NHE-1-mediated inhibition of cell death has mostly been attributed to its ability to extrude H þ upon death triggers, and thereby create an intracellular environment nonpermissive for death execution. However, overexpression of NHE-1 protein in NIH3T3 cells did not significantly affect pHi. This is not surprising because at physiological pHi, NHE-1 is mostly in a quiescent state. Hence, overexpression of a quiescent H þ pump is not expected to significantly alter pHi. On the contrary, expression of an activated form of Rac1 in M14 tumor cells seems to be responsible for the increase in NHE-1 protein level leading to a significant alkanization of the cytosol, while silencing NHE-1 expression had the opposite effect (acidification). The reason for these effects, as opposed to those noted in NIH3T3 cells, could be due to a higher metabolism of M14 tumor cells, in comparison to NIH3T3 cells, or a greater relative dependence upon the Na þ /H þ exchanger for pH regulation. In cells with a low metabolism and low acid production, the Na þ /H þ exchanger may be mostly quiescent. In contrast, in cells with a higher steadystate production of acid, varying NHE1 activity or expression may alter intracellular pH more markedly. For example, heart cells have a high rate of metabolism, 33 and it has been demonstrated that the Na þ /H þ exchanger has a role in steady-state pH regulation. Small though detectable, steadystate rates of Na þ /H þ exchange also occur in neuroblastoma cells 34 and necturus gallbladder, 35 but steady-state pH regulation by the Na þ /H þ exchanger is not detectable in cultured skeletal muscle cells 36 and thymic lymphocytes. 37 In the present study, it appears as though M14 tumor cells fall into the former category, cells with either a high metabolism that requires Na þ /H þ exchanger activity, or cells in which other pH regulatory mechanisms are of lesser importance. More interestingly, both NIH3T3 cells expressing an increased level of NHE-1 compared to the NHE-1 steady-state level in cells grown in 10% serum containing medium and M14RacV12 compared to M14pIRES did not show an increase in their acid-loading recovery capacity. To the contrary, silencing NHE-1 in the same cells led to a decrease in pHi and a lower capacity to recover from an acid load. Taken together these results strongly suggest that two mechanisms could be involved in NHE-1-mediated regulation of cells' response to death trigger. The mechanism involved in the increased cell sensitivity upon decrease in NHE-1 expression may be linked to a lower capacity to recover from an acid load. To the contrary, resistance to death trigger due to overexpression of NHE-1 could be linked to a mechanism that may be independent of an increase in NHE-1 capacity to extrude H þ . Interestingly, two recent reports have demonstrated that activation of NHE-1 induced prosurvival kinase PKB/AKT in human renal proximal tubule epithelial cells 38 and ERK activity in rat aortic vascular smooth muscle cells. 39 In the light of these findings and our data presented here, we propose that redox regulation of NHE-1 expression could indirectly influence activation of two well-known survival pathways, that is, the PI3K/AKT and ERK. If this association is proven to be true, the present report could have tremendous implications in our understanding of redox-regulated sensitivity of cells to death triggers and may uncover the molecular mechanism involved in redox-mediated survival in normal and tumor cells. In summary, this report demonstrates that NHE-1 is a redox-regulated gene and activation of the small GTPase Rac1 activates NHE-1 transcription through intracellular O 2 KÀ production. Moreover, we show that level of NHE-1 protein expression can influence cell sensitivity to death triggers. These findings could provide a mechanism for the regulation of cell survival by ROS, particularly in tumor cells, and may be important in enhancing our understanding of the relationship between cell redox status and tumorigenesis.
Materials and Methods
Chemicals
Staurosporine, DPI, lucigenin, DDC, tiron (4,5-dihydro-1,3 benzene disulfonic acid), anti-b actin antibodies, lucigenin and crystal were purchased from Sigma-Aldrich (LO, USA). Etoposide was purchased from Clonetech Laboratories (CA, USA). DPI, Etoposide and staurosporine stock solutions were prepared in dimethyl sulfoxide (DMSO) at 25, 250 and 1 mM, respectively. Dilutions for the experiments were performed in medium. DDC and tiron were directly diluted in culture medium.
Cell lines
Wild-type NIH3T3 cells (ATCC) were maintained in RPMI medium supplemented with 10% fetal bovine serum (Hyclone, Irvine, CA), 1% glutamineand 0.5% gentamicin (Gibco-BRL, Gaithersburg, MD, USA). NIH3T3 cells stably transfected with a 1.1-kb proximal fragment of the mouse NHE1 promoter/enhancer inserted 5 0 to a luciferase (NIH3-T31A8) 17 or a CAT (NIH3T3CatC2 and NIH3T3CatB3), 17 MCT cells stably transfected with a 1.1-kb proximal fragment of the mouse NHE1 promoter/ enhancer inserted 5 0 to a luciferase gene (MCT 1.1 kb) and L6 cells stably transfected with a 1.1-kb proximal fragment of the mouse NHE1 promoter/ enhancer inserted 5 0 to a luciferase gene (L6 1.1 kb) (34) were maintained in minimum essential medium (MEM), RPMI and DME, respectively, supplemented with 10% fetal bovine serum, 1% glutamine, 0.5% gentamicin (Gibco-BRL, Gaithersburg, MD, USA) and 0.25 mg/ml G418 (Roche Diagnostics Corporation, In, USA). M14 cells stably transfected with a constitutively activated form of Rac (M14RacV12) or the vector control (M14pIRES) 8 were maintained in DMEM supplemented with 5% fetal bovine serum, 1% glutamine, 0.5% gentamicin and 0.25 mg/ml hygromycine (Roche Diagnostics Corporation, IN, USA). The U87 human glioma cells (gift from Dr Tang BL, Department of Biochmistry, National University of Singapore) were maintained in RPMI medium supplemented with 10% fetal bovine serum, 1% glutamine and 0.5% gentamicin.
Plasmids used
The partial myc-tagged loss-of-function mutants of Rac1 containing specific amino-acid substitutions in the activated RacV12 background used in this study were all cloned in the pIRES vector as described previously. 8 pECE plasmid encoding for the human NHE-1 was a generous gift from Dr Pouyssegur, University of Nice, France. pCMV plasmid encoding for the bgalactosidase protein (pCMVb) was from Clonetech Laboratories Inc., Palo Alto, CA.
DNA transfection and reporter assays
All cells were transfected using CalPhost Mammalian transfection kit (Clonetech Laboratories Inc., Palo Alto, CA). In brief, 0.3 Â 10 6 cells/well were plated in 6-well plates 24 h prior to transfection. At 2 h before transfection, the cell culture medium was changed with DMEM supplemented with 5% FBS. To prepare the transfection mixture, 6 mg of DNA, was diluted in sterile dH 2 O in a microfuge tube, followed by the addition of 12.4 ml of 2.5 M CaCl 2 in a total amount of 100 ml/well. The DNACaCl 2 solution was then mixed dropwise with DNA precipitation buffer (100 ml) while gently vortexing, and the mixture was added to the medium of each well, that is, 200 ml per well. After 16 h incubation, the transfection medium was removed and 2 ml/well of 15% glycerol in phosphate-buffered saline (PBS) was added onto the cells for 90 s (glycerol shock). Cells were then washed twice with PBS and normal tissue culture media added for another 24 h. Cotransfection with the bgal plasmid (Clonetech Laboratories Inc., Palo Alto, CA) was used to assess transfection efficiency in reporter assays and used to assess % of cell death when cotransfected with pECE-NHE-1 or the specific NHE-1 siRNA as described previously in Pervaiz et al. 8 bGal activity was measured using the Galacto-Star mammalian reporter Kit (TROPIX, Bedford, MA). Percentage of cell death was measured as 100-((bgal activity mg of protein of transfected cells incubated with the cell death trigger)/(bgal activity mg of protein of transfected cells incubated without the cell death trigger) Â 100).
siRNA transfection 21-nucleotide RNAs were chemically synthesized (Xeragon Inc., Germantown MD, USA). 5 0 -GAUAGGUUUCCAUGUGAUC sequence was used to silence NHE-1 gene transcription (NHE-1siRNA) and 5 0 -AGCUU CAUAAGGCGCAUGCTT (luciferase gene sequence inverted) sequence was used as a control (CosiRNA). Transfection of siRNAs was carried out using oligofectamine (InVitrogen, Life technologies) and 100 nM of siRNAs per well in a six-well plate. Gene silencing was assayed 48 h posttranfection by Western blot analysis.
Luciferase reporter gene assay NHE-1 promoter activity in NIH3T3 1A8, MCT 1.1 kb and L61.1 kb was assessed using the luciferase reporter assay system according to the manufacturer's instructions (Promega, Madison, WI, USA). In brief, cell ) . Viability was assessed using the crystal violet assay and the result is shown as OD at 595 nm. (e) NIH3T3 were either mock transfected (mock) or transfected with 6 mg of pECE-NHE-1 (pECE-NHE-1 6 mg). At 48 h post-transfection cells were incubated with 50 mM H 2 O 2 for 18 h before NHE-1 expression level was assessed or cell death was induced with 40 mM etoposide (eto 40 mM) and measured by caspase activity as described in Materials and Methods after 12 h incubation with etoposide. Results are shown as mean of at least two experiments performed in duplicate7S.E. *Po0.02 lysates were prepared using 200 ml/well of lysis buffer provided by the manufacturer. Cell lysate (20 ml) was mixed with 100 ml of luciferase substrate. Luminescence was measured for 10 s in a TD-20/20 Luminometer (Turner Designs, Sunnyvale, CA).
CAT reporter gene assay
In addition to the luciferase reporter gene assay, NHE-1 promoter was assessed using an enzyme immunoassay to determine the expression of the CAT. The Elisa assay was performed according to the manufacturer's instructions (Roche Diagnostics Corporation Inc., USA). Amount of CAT detected is expressed in pg/ml.
Western blot analysis of the NHE-1 protein
Cell lysates were prepared using 300 ml/well of six-well plates of RIPA/ NP-40 lysis buffer (5 mM Tris pH7.4, 30 mM NaCl, 1 mM PMSF, 1 mg/ml aprotinin and 0.5% NP-40). A 100 mg of total protein per sample was then subjected to 15% PAGE, transferred to nitrocellulose membrane and blocked for 1 h with 5% fat-free milk in Tris-buffered saline/0.1% Tween 20 (TBST). After three washes with TBST, the membranes were exposed to a 1 : 1000 dilution of a mouse antiporcine NHE1 antibody (Chemicon International Inc., Temecula, CA, USA) at 41C overnight. The anti-NHE-1 antibody used here crossreacts with all vertebrate NHE-1 proteins including human. Following three washes with TBST, the membrane was exposed to a 1 : 15 000 dilution of goat anti-mouse IgG-HRP conjugate (PIERCE, Rockford, IL, USA) for 1 h and washed repeatedly with TBST. Chemiluminescence was detected using the SuperSignal Substrate (PIERCE, Rockford, IL, USA). Loading control was assessed by the detection of b actine. NHE-1 and b actine protein intensity were measured using the Analytical Imaging Station software version 2.
Intracellular measurement of superoxide
A lucigenin-based chemiluminescence assay was used for the detection of intracellular O 2 KÀ as described in Pervaiz and Clement. 40 Briefly, cells were washed once with PBS, trypsinized, and centrifuged at 2000 g at room temperature for 1 min. Cell pellets were resuspended and permeabilized in 400 ml of 1 Â somatic cell ATP-releasing reagent (Sigma-Aldrich Pte Singapore). Lucigenin solution (100 ml of 850 mM) was injected automatically before the reading. Chemiluminescence was monitored for 60 s in a TD-20/20 Luminometer (Turner Designs, Sunnyvale, CA).
Crystal violet assay incubation time with the death trigger, the medium was aspirated and replaced for 10 min by 2 ml of 0.75% crystal violet in 50% ethanol, 0.25% NaCl and 1.75% formadehyde solution. Cells were then washed with water, air dried and the dye eluted with PBS/1%SDS. Viability was assessed by dye absorbance determined by optical density (OD) measurement at 595 nm on a Spectrafluorplus plate reader (TECAN). Percentage of cell death was assessed as 1À(OD from cells incubated with the death trigger/OD from control cells) Â 100.
Caspase activity assay
Cells were harvested after drug treatment and lysed using 1 Â cell lysis buffer (BD Biosciences Pharmingen, San Diego, CA). Cell lysate was added to 2 Â reaction buffer (10 mM HEPES, pH7.4, 2 mM EDTA, 6 mM DTT, 10 mM KCl and 1.5 mM MgCl 2 ) supplemented with protease inhibitors and caspase substrate (50 mM) (caspase 3 substrate: Ac-DEVD-AFC) (A.G. Scientific, San Diego, CA) in a 96-well plate. Samples were incubated at 371C for 1 h and AFC fluorescence was measured using SpectrafluorPlus spectrofluorometer. Caspase activity was normalized with protein amount and expressed as relative fluorescence unit/mg of protein (RFU/mg of protein).
Measurement of intracellular pH and NHE-1 activity
Cells were washed and incubated with 5 mM of BCECF-AM in HCO 3 À -free HEPES buffer (135 mM NaCl, 5 mM KCl, 1.8 mM CaCl 2 , 1 mM MgSO 4 , 5.5 mM glucose, 10 mM HEPES and pH7.4) for 30 min at 371C. The cells were washed and fluorescence of BCECF was measured (excitation at 485 and 430 nm; emission at 535 nm). pHi was derived by determining the ratio of dual excitation measurement (485 : 430 nm) from a pHi standard curve. To calibrate the relationship between the excitation ratio (485 : 430 nm) and pH, cells loaded with 5 mM BCECF-AM were incubated with 10 mM nigericin for 3 min in high K þ buffer of pH 6.4-8.0, obtained by mixing pH 4 buffer (140 mM KH 2 PO 4 and 20 mM NaCl) and pH 9 buffer (70 mM K 2 HPO 4 and 20 mM NaCl), and fluorescence measurement was taken. After measurement of pHi, the cells were acid loaded with HCO 3 À -free HEPES buffer containing 30 mM NH 4 Cl, pH7.4 for 8 min. The cells were then exposed to Na þ -free and HCO 3 À -free HEPES buffer (135 mM N-methyl glucamine, 5 mM KCl, 1.8 mM CaCl 2 , 1 mM MgSO 4 , 5.5 mM glucose, 10 mM HEPES and pH7.4) for 30 s and subsequently washed with HEPES buffer. The pH recovery from acid load was monitored every minute for 15 min and NHE-1 activity was determined by the rate of pHi recovery within the first 2 min and is expressed as DpH/Dtime (DpH/Dt).
Statistical analysis
Statistical analysis was performed using the paired Student's t-test with Po0.05 considered significant.
